Revvity Inc (RVTY)
124.82
+3.78
(+3.12%)
USD |
NYSE |
Nov 04, 16:00
124.76
-0.06
(-0.05%)
After-Hours: 20:00
Revvity Debt to Equity Ratio: 0.4922 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2024 | 0.4922 |
March 31, 2024 | 0.494 |
December 31, 2023 | 0.4953 |
September 30, 2023 | 0.5043 |
June 30, 2023 | 0.5543 |
March 31, 2023 | 0.5428 |
December 31, 2022 | 0.5952 |
September 30, 2022 | 0.623 |
June 30, 2022 | 0.6263 |
March 31, 2022 | 0.6774 |
December 31, 2021 | 0.6979 |
September 30, 2021 | 0.7334 |
June 30, 2021 | 0.555 |
March 31, 2021 | 0.6442 |
December 31, 2020 | 0.5329 |
September 30, 2020 | 0.5733 |
June 30, 2020 | 0.6643 |
March 31, 2020 | 0.732 |
December 31, 2019 | 0.7371 |
September 30, 2019 | 0.834 |
June 30, 2019 | 0.7805 |
March 31, 2019 | 0.7058 |
December 31, 2018 | 0.7317 |
September 30, 2018 | 0.7396 |
June 30, 2018 | 0.795 |
Date | Value |
---|---|
March 31, 2018 | 0.813 |
December 31, 2017 | 0.8014 |
September 30, 2017 | 0.4379 |
June 30, 2017 | 0.4476 |
March 31, 2017 | 0.4775 |
December 31, 2016 | 0.4859 |
September 30, 2016 | 0.5306 |
June 30, 2016 | 0.5067 |
March 31, 2016 | 0.547 |
December 31, 2015 | 0.4799 |
September 30, 2015 | 0.5006 |
June 30, 2015 | 0.466 |
March 31, 2015 | 0.4931 |
December 31, 2014 | 0.5124 |
September 30, 2014 | 0.4168 |
June 30, 2014 | 0.4355 |
March 31, 2014 | 0.458 |
December 31, 2013 | 0.4687 |
September 30, 2013 | 0.4876 |
June 30, 2013 | 0.5399 |
March 31, 2013 | 0.5597 |
December 31, 2012 | 0.4849 |
September 30, 2012 | 0.48 |
June 30, 2012 | 0.4832 |
March 31, 2012 | 0.4961 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.4922
Minimum
Jun 2024
0.7371
Maximum
Dec 2019
0.6039
Average
0.5952
Median
Dec 2022
Debt to Equity Ratio Benchmarks
Bionano Genomics Inc | 0.241 |
Avantor Inc | 0.8862 |
Bruker Corp | 1.206 |
Azenta Inc | 0.00 |
Harvard Bioscience Inc | 0.5306 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 13.42B |
Total Liabilities (Quarterly) | 5.555B |
Shareholders Equity (Quarterly) | 7.870B |
Current Ratio | 2.272 |
Net Debt Paydown Yield | 0.75% |